Laurent, A., Siret, A., Ignacimouttou, C., Panchal, K., Diop, M., Jenni, S., . . . Malinge, S. (2020). Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia. AMER ASSOC CANCER RESEARCH.
Chicago Style (17th ed.) CitationLaurent, A.P, et al. Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia. AMER ASSOC CANCER RESEARCH, 2020.
MLA (9th ed.) CitationLaurent, A.P, et al. Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia. AMER ASSOC CANCER RESEARCH, 2020.
Warning: These citations may not always be 100% accurate.